Psychotropic plant medicine has garnered immense attention as more of such products, most notably cannabidiol (CBD) nutraceuticals, and even foods and beverages, enter the mainstream market.
The nutraceutical industry offers more opportunities for developing new products beneficial to patients compared to the pharma industry, but more science-based evidence is needed, according to a leading Indian academic who stars in our second Nutra Champions...
AB Biotics has pledged to continue investing in clinical research to back-up the cognitive benefits of L. plantarum DR7 after acquiring the exclusive global licensing of the strain.
Social commerce is a much-talked about topic in China’s health foods retail landscape, with firm’s using everything from WeChat, Tiktok, Little Red Book, and Kuaishou to target consumers.
A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.
The growing body evidence supporting the benefits of probiotics for prenatal health are opening up “exciting and unique” opportunities for new product development, according to an industry expert from DuPont.
The landscape of the probiotics industry has changed drastically in recent years, with more firms creating products that seek to improve a wide variety of health conditions, aside from gut health.
Four years after its launch, Japan’s Food with Function market now encompasses 2,409 products with the sector set to hit the US$2.5 billion mark this year.
The work being undertaken by trade body GOED to catalogue 4,000-plus human clinical trials on omega-3 will be showcased at the organisation’s forthcoming GOED Exchange in Barcelona.
